| (EUR) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 341.60B | — |
| Operating expense | — | — |
| Net income | 116.30B | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, CUP.F returned -31.7% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | -226.2% |
| 1 year | -31.7% |
| 5 years | +17279.6% |
| 10 years | +1730150768712.3% |
| All-time high | €56.02 (Feb 2026) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what €1,000 in CUP.F would be worth today ›Yes. Chugai Pharmaceutical Co., Ltd. paid 2 dividends over the past 12 months. The most recent was €0.36 per share on Jun 29, 2026. The dividend yield is 1.94%.
Chugai Pharmaceutical Co., Ltd. is part of the Healthcare sector.
Chugai Pharmaceutical Co., Ltd. has a market cap of 61.07B EUR, based on the latest quote.
Chugai Pharmaceutical Co., Ltd. is scheduled to report earnings on Oct 27, 2026.
